JAMES J WEIDEL
- Type
- Non-physician practitioner · Physician Assistants & Advanced Practice Nursing Providers / Nurse Practitioner / Psychiatric/Mental Health
- Where
- CAIRO, NY
- NPI
- 1073790564
- Received
- $2,969 in 146 records, 2021 to 2025
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 100 | $1,758 |
| 2024 | General payment | 26 | $597 |
| 2023 | General payment | 12 | $345 |
| 2022 | General payment | 2 | $51 |
| 2021 | General payment | 6 | $216 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 28 | $703 | 2023–2025 |
| Otsuka America Pharmaceutical, Inc. | 16 | $392 | 2023–2025 |
| Vanda Pharmaceuticals Inc. | 13 | $249 | 2024–2025 |
| E.R. Squibb & Sons, L.L.C. | 16 | $241 | 2025 |
| Alkermes, Inc. | 17 | $234 | 2024–2025 |
| ABBVIE INC. | 13 | $232 | 2024–2025 |
| Teva Pharmaceuticals USA, Inc. | 5 | $189 | 2021 |
| Axsome Therapeutics, Inc. | 11 | $169 | 2024–2025 |
| Corium, LLC | 8 | $162 | 2022–2024 |
| Supernus Pharmaceuticals, Inc. | 8 | $151 | 2023–2025 |
| Braeburn Inc. | 3 | $62 | 2024–2025 |
| IRONSHORE PHARMACEUTICALS INC. | 2 | $59 | 2024 |
| Janssen Pharmaceuticals, Inc | 2 | $29 | 2025 |
| Neurocrine BioSciences, Inc. | 1 | $27 | 2021 |
| Lundbeck LLC | 1 | $26 | 2025 |
| Indivior Inc. | 1 | $18 | 2025 |
| Orexo US, Inc. | 1 | $18 | 2023 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Food and Beverage | 145 | $2,920 |
| Education | 1 | $48 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-17 | ABBVIE INC. | $12 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-12-17 | E.R. Squibb & Sons, L.L.C. | $7 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-12-10 | Vanda Pharmaceuticals Inc. | $7 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-12-10 | Vanda Pharmaceuticals Inc. | $5 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-12-09 | E.R. Squibb & Sons, L.L.C. | $19 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-12-09 | E.R. Squibb & Sons, L.L.C. | $3 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-12-04 | Otsuka America Pharmaceutical, Inc. | $24 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-12-03 | Axsome Therapeutics, Inc. | $14 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-11-26 | Alkermes, Inc. | $14 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-11-17 | Supernus Pharmaceuticals, Inc. | $20 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2025 | |
| 2025-11-12 | E.R. Squibb & Sons, L.L.C. | $17 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-11-12 | E.R. Squibb & Sons, L.L.C. | $3 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-11-10 | ABBVIE INC. | $4 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-11-07 | Alkermes, Inc. | $7 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-11-07 | ABBVIE INC. | $4 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-11-07 | Alkermes, Inc. | $1 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-11-05 | Axsome Therapeutics, Inc. | $18 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-10-30 | Otsuka America Pharmaceutical, Inc. | $17 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-10-30 | Otsuka America Pharmaceutical, Inc. | $1 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-10-29 | Vanda Pharmaceuticals Inc. | $14 | Food and Beverage | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-10-22 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $108 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-21 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $9 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-14 | E.R. Squibb & Sons, L.L.C. | $18 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-14 | E.R. Squibb & Sons, L.L.C. | $2 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-09 | Alkermes, Inc. | $25 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-10-08 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $13 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-09-30 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $12 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-09-24 | Alkermes, Inc. | $17 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-09-23 | Lundbeck LLC | $26 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-09-23 | E.R. Squibb & Sons, L.L.C. | $17 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-09-17 | Otsuka America Pharmaceutical, Inc. | $24 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-09-16 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-09-15 | Supernus Pharmaceuticals, Inc. | $18 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2025 | |
| 2025-09-12 | Alkermes, Inc. | $11 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-09-11 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $21 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-09-08 | Indivior Inc. | $18 | Food and Beverage | In-kind items and services | SUBLOCADE Drug, OUD | 2025 | |
| 2025-09-03 | Axsome Therapeutics, Inc. | $1 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-09-02 | Axsome Therapeutics, Inc. | $12 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-08-29 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $12 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-08-27 | Otsuka America Pharmaceutical, Inc. | $24 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-08-26 | ABBVIE INC. | $26 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-08-25 | Supernus Pharmaceuticals, Inc. | $23 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2025 | |
| 2025-08-20 | E.R. Squibb & Sons, L.L.C. | $18 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-08-19 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $13 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-08-18 | Alkermes, Inc. | $21 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-08-13 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-08-12 | Vanda Pharmaceuticals Inc. | $14 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-08-07 | Alkermes, Inc. | $8 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-07-29 | Vanda Pharmaceuticals Inc. | $13 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-07-24 | Alkermes, Inc. | $0 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-07-23 | Alkermes, Inc. | $21 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-07-22 | E.R. Squibb & Sons, L.L.C. | $23 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-07-21 | Axsome Therapeutics, Inc. | $20 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-07-16 | ABBVIE INC. | $19 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-07-15 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $17 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-07-14 | Supernus Pharmaceuticals, Inc. | $22 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2025 | |
| 2025-07-09 | Otsuka America Pharmaceutical, Inc. | $20 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-07-02 | ABBVIE INC. | $26 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-06-27 | Alkermes, Inc. | $16 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-06-27 | Janssen Pharmaceuticals, Inc | $14 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2025 | |
| 2025-06-26 | ABBVIE INC. | $24 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-06-26 | Axsome Therapeutics, Inc. | $2 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-06-25 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $22 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-06-20 | E.R. Squibb & Sons, L.L.C. | $20 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-06-20 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $12 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-06-11 | Vanda Pharmaceuticals Inc. | $13 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-06-03 | Axsome Therapeutics, Inc. | $17 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-06-03 | Alkermes, Inc. | $11 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-06-03 | Alkermes, Inc. | $6 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-05-28 | ABBVIE INC. | $32 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-05-23 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $19 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-05-23 | Janssen Pharmaceuticals, Inc | $15 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2025 | |
| 2025-05-21 | E.R. Squibb & Sons, L.L.C. | $16 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-05-19 | Axsome Therapeutics, Inc. | $26 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-05-14 | Braeburn Inc. | $17 | Food and Beverage | In-kind items and services | BRIXADI Drug, Opioid Use Disorder | 2025 | |
| 2025-05-10 | ABBVIE INC. | $8 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-05-09 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $13 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-05-09 | Alkermes, Inc. | $11 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-05-07 | Otsuka America Pharmaceutical, Inc. | $25 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-04-30 | Vanda Pharmaceuticals Inc. | $106 | Food and Beverage | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-04-30 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $16 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-04-28 | Axsome Therapeutics, Inc. | $20 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-04-23 | E.R. Squibb & Sons, L.L.C. | $28 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-04-22 | Vanda Pharmaceuticals Inc. | $7 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-04-16 | Alkermes, Inc. | $16 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-04-09 | Vanda Pharmaceuticals Inc. | $16 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-04-01 | Otsuka America Pharmaceutical, Inc. | $18 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-03-26 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $16 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-03-21 | Vanda Pharmaceuticals Inc. | $9 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-03-20 | Braeburn Inc. | $18 | Food and Beverage | In-kind items and services | BRIXADI Drug, Opioid Use Disorder | 2025 | |
| 2025-03-19 | Alkermes, Inc. | $20 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-03-12 | E.R. Squibb & Sons, L.L.C. | $19 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-03-12 | E.R. Squibb & Sons, L.L.C. | $0 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-02-26 | Vanda Pharmaceuticals Inc. | $14 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-02-17 | Supernus Pharmaceuticals, Inc. | $16 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2025 | |
| 2025-02-12 | Otsuka America Pharmaceutical, Inc. | $24 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-02-05 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $15 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-01-29 | E.R. Squibb & Sons, L.L.C. | $24 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-01-21 | Vanda Pharmaceuticals Inc. | $12 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-01-13 | Axsome Therapeutics, Inc. | $19 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2024-12-18 | ABBVIE INC. | $21 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-12-10 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $13 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-11-26 | Braeburn Inc. | $26 | Food and Beverage | In-kind items and services | BRIXADI Drug, Opioid Use Disorder | 2024 | |
| 2024-11-20 | Otsuka America Pharmaceutical, Inc. | $18 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-11-20 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $11 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-11-13 | Alkermes, Inc. | $20 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2024 | |
| 2024-11-06 | Vanda Pharmaceuticals Inc. | $14 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2024 | |
| 2024-10-30 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $16 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-10-22 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-10-15 | Otsuka America Pharmaceutical, Inc. | $19 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-10-09 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $17 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-07-18 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $20 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-06-07 | Axsome Therapeutics, Inc. | $14 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2024 | |
| 2024-06-07 | Corium, LLC | $5 | Food and Beverage | In-kind items and services | Azstarys Drug, CNS Stimulant for ADHD | 2024 | |
| 2024-06-06 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $19 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-05-23 | Corium, LLC | $18 | Food and Beverage | In-kind items and services | Azstarys Drug, CNS Stimulant for ADHD | 2024 | |
| 2024-05-03 | Supernus Pharmaceuticals, Inc. | $17 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2024 | |
| 2024-05-02 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $21 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-04-25 | Corium, LLC | $20 | Food and Beverage | In-kind items and services | Azstarys Drug, CNS Stimulant for ADHD | 2024 | |
| 2024-03-28 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $20 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-03-27 | IRONSHORE PHARMACEUTICALS INC. | $24 | Food and Beverage | Cash or cash equivalent | JORNAY PM Drug, CENTRAL NERVOUS SYSTEM STIMULANT | 2024 | |
| 2024-03-21 | Otsuka America Pharmaceutical, Inc. | $16 | Food and Beverage | In-kind items and services | ABILIFY ASIMTUFII Drug, PSYCHIATRY | 2024 | |
| 2024-02-23 | IRONSHORE PHARMACEUTICALS INC. | $34 | Food and Beverage | Cash or cash equivalent | JORNAY PM Drug, CENTRAL NERVOUS SYSTEM STIMULANT | 2024 | |
| 2024-02-22 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $19 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-01-23 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $130 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-01-04 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $16 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2023-12-21 | Corium, LLC | $20 | Food and Beverage | In-kind items and services | Azstarys Drug, CNS Stimulant for ADHD | 2023 | |
| 2023-11-13 | Supernus Pharmaceuticals, Inc. | $15 | Food and Beverage | Cash or cash equivalent | QELBREE Drug, PSYCHOLOGY | 2023 | |
| 2023-11-09 | Otsuka America Pharmaceutical, Inc. | $14 | Food and Beverage | In-kind items and services | ABILIFY ASIMTUFII Drug, PSYCHIATRY | 2023 | |
| 2023-08-21 | Otsuka America Pharmaceutical, Inc. | $14 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2023 | |
| 2023-07-20 | Corium, LLC | $14 | Food and Beverage | In-kind items and services | Azstarys Drug, CNS Stimulant for ADHD | 2023 | |
| 2023-05-23 | Otsuka America Pharmaceutical, Inc. | $115 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2023 | |
| 2023-05-05 | Otsuka America Pharmaceutical, Inc. | $13 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2023 | |
| 2023-04-22 | Supernus Pharmaceuticals, Inc. | $19 | Food and Beverage | Cash or cash equivalent | QELBREE Drug, PSYCHOLOGY | 2023 | |
| 2023-04-20 | Corium, LLC | $30 | Food and Beverage | In-kind items and services | Azstarys Drug, CNS Stimulant for ADHD | 2023 | |
| 2023-04-19 | Orexo US, Inc. | $18 | Food and Beverage | Cash or cash equivalent | Zubsolv Drug, Addiction Medicine | 2023 | |
| 2023-03-03 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $48 | Education | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-03-03 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $20 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2022-12-22 | Corium, LLC | $28 | Food and Beverage | In-kind items and services | AZSTARYS Drug, CNS Stimulant for ADHD | 2022 | |
| 2022-11-07 | Corium, LLC | $22 | Food and Beverage | In-kind items and services | AZSTARYS Drug, CNS Stimulant for ADHD | 2022 | |
| 2021-08-17 | Teva Pharmaceuticals USA, Inc. | $125 | Food and Beverage | In-kind items and services | AUSTEDO Drug, Central Nervous System | 2021 | |
| 2021-04-17 | Teva Pharmaceuticals USA, Inc. | $16 | Food and Beverage | In-kind items and services | AUSTEDO Drug, Central Nervous System | 2021 | |
| 2021-04-03 | Neurocrine BioSciences, Inc. | $27 | Food and Beverage | In-kind items and services | INGREZZA Drug, NEUROLOGY | 2021 | |
| 2021-03-20 | Teva Pharmaceuticals USA, Inc. | $16 | Food and Beverage | In-kind items and services | AUSTEDO Drug, Central Nervous System | 2021 | |
| 2021-02-13 | Teva Pharmaceuticals USA, Inc. | $16 | Food and Beverage | In-kind items and services | AUSTEDO Drug, Central Nervous System | 2021 | |
| 2021-01-30 | Teva Pharmaceuticals USA, Inc. | $16 | Food and Beverage | In-kind items and services | AUSTEDO Drug, Central Nervous System | 2021 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Cairo, NY, county Greene County, NY, state New York; placed by its city name.
| Measure | Place (city or town) Cairo, NY | County Greene County, NY | State New York |
|---|---|---|---|
| Population B01003 | 1,660 | 47,409 | 19,852,366 |
| Population, 2020 census P1 | 1,368 | 47,931 | 20,201,249 |
| Median age B01002 | 35.2 | 47.4 | 39.8 |
| Under 18 B01001 | 24.3% | 16.2% | 20.5% |
| 65 and over B01001 | 14.9% | 24.1% | 17.9% |
| Households B11001 | 628 | 18,674 | 7,722,646 |
| Foreign born B05002 | 10.4% | 5.2% | 22.8% |
| Median household income B19013 | $81,885 | $77,945 | $85,974 |
| Median family income B19113 | $91,538 | $101,009 | $106,873 |
| Per capita income B19301 | $73,444 | $44,090 | $50,712 |
| Poverty rate B17001 | 6.5% | 9.9% | 14.0% |
| Unemployment rate B23025 | 0.0% | 3.9% | 6.4% |
| Civilian labor force B23025 | 861 | 22,735 | 10,171,766 |
| Mean commute (minutes) B08013 | 27.2 | 28.9 | 32.6 |
| Bachelor's degree or higher B15003 | 28.6% | 29.9% | 40.2% |
| Housing units B25001 | 770 | 29,080 | 8,585,241 |
| Owner-occupied B25003 | 54.0% | 77.2% | 54.3% |
| Renters B25003 | 46.0% | 22.8% | 45.7% |
| Median home value B25077 | $237,700 | $271,600 | $423,800 |
| Median gross rent B25064 | $1,568 | $1,004 | $1,621 |
| White, not Hispanic B03002 | 76.9% | 82.8% | 52.8% |
| Black B03002 | 15.4% | 4.5% | 13.4% |
| Hispanic or Latino B03002 | 5.6% | 6.8% | 19.8% |
| Asian B03002 | 0.0% | 1.2% | 9.0% |
| American Indian and Alaska Native B03002 | 0.0% | 0.1% | 0.2% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Cairo, NY.
Comments